Identification of Hub Genes Associated with Pyroptosis in Diabetic Nephropathy Patients Using Integrated Bioinformatic Analysis

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 2024 Jul 19

PMID 39028495

Authors

Qiuli Wang

Yan Zhou

Nan Zheng

Feng Jiang

Chenxia Juan

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate the role of pyroptosis in diabetic nephropathy (DN) and identify potential biomarkers for diagnosis.

Methods: We analyzed the GEO dataset GSE96804 to identify differentially expressed genes (DEGs) related to pyroptosis in DN. The CIBERSORT method was used to assess M1 macrophage infiltration in the samples. Using weighted gene co-expression network analysis (WGCNA), we identified gene modules associated with M1 macrophages. The least absolute shrinkage and selection operator (LASSO) method was then applied to screen for key genes. The intersection of key genes identified by LASSO and the gene modules obtained from WGCNA resulted in the identification of ten hub genes as potential biomarkers for DN.

Results: A total of 366 DEGs were identified, with 310 genes associated with pyroptosis. Increased M1 macrophage infiltration was observed in DN patients. Ten hub genes were identified as potential DN biomarkers: ECM1, LRP2BP, ALKBH7, CDH10, DUSP1, HSPA1A, LPL, NFIL3, PDK4, and TMEM150C.

Conclusions: This study highlights the importance of pyroptosis in DN pathophysiology and identifies 10 hub genes as potential biomarkers. These findings may contribute to improved diagnosis and treatment of DN.

References

Umanath K, Lewis J . Update on Diabetic Nephropathy: Core Curriculum 2018. Am J Kidney Dis. 2018; 71(6):884-895. DOI: 10.1053/j.ajkd.2017.10.026. View

Moreno J, Gomez-Guerrero C, Mas S, Sanz A, Lorenzo O, Ruiz-Ortega M . Targeting inflammation in diabetic nephropathy: a tale of hope. Expert Opin Investig Drugs. 2018; 27(11):917-930. DOI: 10.1080/13543784.2018.1538352. View

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

Juan J, Yang H . Prevalence, Prevention, and Lifestyle Intervention of Gestational Diabetes Mellitus in China. Int J Environ Res Public Health. 2020; 17(24). PMC: 7766930. DOI: 10.3390/ijerph17249517. View

Sagoo M, Gnudi L . Diabetic Nephropathy: An Overview. Methods Mol Biol. 2019; 2067:3-7. DOI: 10.1007/978-1-4939-9841-8_1. View

Shen Z, Fang Y, Xing T, Wang F . Diabetic Nephropathy: From Pathophysiology to Treatment. J Diabetes Res. 2017; 2017:2379432. PMC: 5672629. DOI: 10.1155/2017/2379432. View

Lu Y, Liu D, Feng Q, Liu Z . Diabetic Nephropathy: Perspective on Extracellular Vesicles. Front Immunol. 2020; 11:943. PMC: 7283536. DOI: 10.3389/fimmu.2020.00943. View

Natesan V, Kim S . Diabetic Nephropathy - a Review of Risk Factors, Progression, Mechanism, and Dietary Management. Biomol Ther (Seoul). 2021; 29(4):365-372. PMC: 8255138. DOI: 10.4062/biomolther.2020.204. View

Shi J, Gao W, Shao F . Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. Trends Biochem Sci. 2016; 42(4):245-254. DOI: 10.1016/j.tibs.2016.10.004. View

10.

Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang Y . Pyroptosis: A new frontier in cancer. Biomed Pharmacother. 2019; 121:109595. DOI: 10.1016/j.biopha.2019.109595. View

11.

Man S, Karki R, Kanneganti T . Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017; 277(1):61-75. PMC: 5416822. DOI: 10.1111/imr.12534. View

12.

Qian Z, Zhao Y, Wan C, Deng Y, Zhuang Y, Xu Y . Pyroptosis in the Initiation and Progression of Atherosclerosis. Front Pharmacol. 2021; 12:652963. PMC: 8187899. DOI: 10.3389/fphar.2021.652963. View

13.

Yu Z, Zhang J, Li X, Wang Y, Fu Y, Gao X . A new research hot spot: The role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications. Life Sci. 2019; 240:117138. DOI: 10.1016/j.lfs.2019.117138. View

14.

Al Mamun A, Wu Y, Nasrin F, Akter A, Taniya M, Munir F . Role of Pyroptosis in Diabetes and Its Therapeutic Implications. J Inflamm Res. 2021; 14:2187-2206. PMC: 8164340. DOI: 10.2147/JIR.S291453. View

15.

Li W, Sun J, Zhou X, Lu Y, Cui W, Miao L . Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy. Front Pharmacol. 2021; 12:780790. PMC: 8637879. DOI: 10.3389/fphar.2021.780790. View

16.

Lin J, Cheng A, Cheng K, Deng Q, Zhang S, Lan Z . New Insights into the Mechanisms of Pyroptosis and Implications for Diabetic Kidney Disease. Int J Mol Sci. 2020; 21(19). PMC: 7583981. DOI: 10.3390/ijms21197057. View

17.

Nakayama M, Michels A . Using the T Cell Receptor as a Biomarker in Type 1 Diabetes. Front Immunol. 2021; 12:777788. PMC: 8635517. DOI: 10.3389/fimmu.2021.777788. View

18.

James E, Mallone R, Kent S, DiLorenzo T . T-Cell Epitopes and Neo-epitopes in Type 1 Diabetes: A Comprehensive Update and Reappraisal. Diabetes. 2020; 69(7):1311-1335. PMC: 7306130. DOI: 10.2337/dbi19-0022. View

19.

Clark M, Kroger C, Ke Q, Tisch R . The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes. Front Immunol. 2021; 11:615371. PMC: 7884625. DOI: 10.3389/fimmu.2020.615371. View

20.

Arif S, Pujol-Autonell I, Kamra Y, Williams E, Yusuf N, Domingo-Vila C . Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes Subjects. Front Immunol. 2021; 12:675746. PMC: 8274489. DOI: 10.3389/fimmu.2021.675746. View